Clinical Trial Update: Prevention of Post-STEMI Left Ventricular Thrombus With Optimized Anticoagulant (EARLYmyo-LVT Ⅱ) [Phase 3]

View source ↗

Summary

Phase 3 trial update on preventing post-STEMI left ventricular thrombus with optimized anticoagulation (EARLYmyo-LVT II).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Left Ventricular Thrombus
• St-segment Elevation Myocardial Infarction

Snippet

Sponsor: RenJi Hospital | Conditions: ST Segment Elevation Myocardial Infarction, Left Ventricular Thrombus | Phase 3 | Status: UNKNOWN